Literature DB >> 34217879

Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study).

Yasushi Yamasaki1, Noriya Uedo2, Takuji Akamatsu3, Tomo Kagawa4, Reiji Higashi5, Osamu Dohi6, Masanori Furukawa7, Yu Takahashi8, Takuya Inoue9, Shouichi Tanaka10, Ryuta Takenaka11, Mikitaka Iguchi12, Takuji Kawamura13, Takao Tsuzuki14, Tomoaki Yamasaki15, Takeshi Yamashina16, Junichiro Nasu17, Tomohiko Mannami18, Atsushi Yamauchi19, Kazuhiro Matsueda20, Shigeyuki Aizawa21, Toshiharu Mitsuhashi22, Hiroyuki Okada1.   

Abstract

BACKGROUND AND AIMS: Endoscopic resection of nonampullary duodenal adenoma is often challenging, and its technique has not yet been standardized. To overcome the practical difficulty of conventional endoscopic mucosal resection, underwater endoscopic mucosal resection (UEMR) was recently developed; therefore, we investigated the effectiveness and safety of UEMR for nonampullary duodenal adenoma.
METHODS: A multicenter, prospective cohort study was conducted at 21 institutions in Japan. We enrolled patients with no more than 2 nonampullary duodenal adenomas ≤20 mm in size, who were planned to undergo UEMR. After UEMR, follow-up endoscopies were scheduled at 2 and 12 months after the procedure, and biopsy specimens were taken from the post-UEMR scars. The primary endpoint was the proportion of patients with histologically proven nonrecurrence at follow-up endoscopy and biopsy.
RESULTS: A total of 155 patients with 166 lesions underwent UEMR. One patient with a non-neoplastic lesion in the resected specimen and 10 patients with 10 lesions who were lost to follow-up were excluded. Finally, 144 patients with 155 lesions who received all follow-up endoscopies were analyzed for the primary endpoint. The proportion of patients with proven nonrecurrence was 97.2% (n = 140 of 144; 95% confidence interval, 92.8%-99.1%) which exceeded the predefined threshold value (92%). Two cases of delayed bleeding (1.2%) occurred and they were successfully managed by clips. All recurrences were successfully treated by additional endoscopic treatment.
CONCLUSIONS: This multicenter, prospective cohort study demonstrated effectiveness and safety of UEMR for nonampullary duodenal adenomas ≤20 mm in size. (University Hospital Medical Network Clinical Trials Registry, Number: UMIN000030414).
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Duodenal Adenoma; Follow-Up; Nonrecurrence Rate; Underwater Endoscopic Mucosal Resection

Mesh:

Year:  2021        PMID: 34217879     DOI: 10.1016/j.cgh.2021.06.043

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  3 in total

1.  Prospective multicenter study of the efficacy and safety of cold forceps polypectomy for ≤ 6-mm non-ampullary duodenal low-grade adenomas.

Authors:  Hiromitsu Kanzaki; Joichiro Horii; Ryuta Takenaka; Hiroyuki Nakagawa; Kazuhiro Matsueda; Takao Tsuzuki; Masahide Kita; Yasushi Yamasaki; Takehiro Tanaka; Masaya Iwamuro; Seiji Kawano; Yoshiro Kawahara; Jun Tomoda; Hiroyuki Okada
Journal:  Endosc Int Open       Date:  2022-06-10

2.  Gel Immersion Endoscopic Mucosal Resection (EMR) for Superficial Nonampullary Duodenal Epithelial Tumors May Reduce Procedure Time Compared with Underwater EMR (with Video).

Authors:  Takeshi Yamashina; Masaaki Shimatani; Yu Takahashi; Masahiro Takeo; Natsuko Saito; Hironao Matsumoto; Takeshi Kasai; Masataka Kano; Kimi Sumimoto; Toshiyuki Mitsuyama; Hiroyuki Marusawa; Akiyoshi Nishio; Takafumi Yuba; Toshihito Seki; Makoto Naganuma
Journal:  Gastroenterol Res Pract       Date:  2022-06-15       Impact factor: 1.919

Review 3.  Endoscopic resection of superficial non-ampullary duodenal epithelial tumor.

Authors:  Motohiko Kato; Takanori Kanai; Naohisa Yahagi
Journal:  DEN open       Date:  2021-09-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.